MedTrace Logo

Caprini Score in Venous Surgery: a Prospective Cohort Study

NCT03041805 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-03-02

No results posted yet for this study

Summary

The aim of the study is to make a validation of Caprini score in patients undergoing varicose veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT, radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit from prophylactic anticoagulation.

Conditions

  • Venous Thromboembolism
  • Varicose Veins

Interventions

PROCEDURE

EVLT

Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type

PROCEDURE

RFA

Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique

PROCEDURE

USFS

Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration

PROCEDURE

HL/stripping

High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein

PROCEDURE

Miniphlebectomy

Miniphlebectomy of any varicose veins under local, regional or general anaesthesia

PROCEDURE

Sclerotherapy

Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration

DEVICE

GCS

Graduated compression stockings may be used after procedure by the decision of the doctor

DRUG

LMWH

Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Sponsors & Collaborators

  • Pirogov Russian National Research Medical University

    lead OTHER

Principal Investigators

  • Kirill Lobastov, PhD · Pirogov Russian National Research Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2027-01-01
Completion
2027-01-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03041805 on ClinicalTrials.gov